Bullfrog AI Holdings Price to Sales Ratio 2022-2025 | BFRG
Historical PS ratio values for Bullfrog AI Holdings (BFRG) over the last 10 years. The current P/S ratio for Bullfrog AI Holdings as of May 15, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bullfrog AI Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-15 | 1.71 | 0.00 | |
| 2025-03-31 | 1.65 | 0 | 0.00 |
| 2024-12-31 | 2.00 | 0 | 0.00 |
| 2024-09-30 | 2.87 | 0 | 0.00 |
| 2024-06-30 | 1.73 | $0.01 | 162.21 |
| 2024-03-31 | 3.21 | $0.01 | 300.98 |
| 2023-12-31 | 3.26 | $0.01 | 305.67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.017B | $0.000B |
| BullFrog AI Holdings Inc. is a digital biopharmaceutical company which focuses on artificial intelligence and machine learning driven analysis of data sets in medicine and healthcare principally in the United States. BullFrog AI Holdings Inc. is based in Gaithersburg, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.096B | 54.00 |
| Hims & Hers Health (HIMS) | United States | $13.681B | 142.14 |
| Tempus AI (TEM) | United States | $11.156B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.596B | 71.81 |
| IRhythm Technologies (IRTC) | United States | $4.484B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.069B | 11.53 |
| Schrodinger (SDGR) | United States | $1.747B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.691B | 0.00 |
| Phreesia (PHR) | United States | $1.537B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.74 |
| Azenta (AZTA) | United States | $1.233B | 57.32 |
| 10x Genomics (TXG) | United States | $1.115B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 154.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Claritev (CTEV) | United States | $0.435B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 825.00 |
| Health Catalyst (HCAT) | United States | $0.291B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |